Differential Survival characteristics of sarcomatoid subtype biphasic pleural mesothelioma

ConclusionsBPM prognosis remains poor despite multimodality treatment. Anti-cancer treatment is associated with superior outcome in this non-randomised retrospective series. Our findings suggest superior survival for those with a lower proportion of sarcomatoid disease, with selective benefit of RT in higher proportions of sarcomatoid disease. When planning active treatment, the potential survival benefits require balancing against associated morbidity and recovery period.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research